Vaccination with recombinant Modified Vaccinia Ankara (MVA) viruses expressing single African horse sickness virus VP2 antigens induced cross-reactive virus neutralising antibodies (VNAb) in horses when administered in combination

首页> 外文期刊>Vaccine >Vaccination with recombinant Modified Vaccinia Ankara (MVA) viruses expressing single African horse sickness virus VP2 antigens induced cross-reactive virus neutralising antibodies (VNAb) in horses when administered in combination

【24h】

Vaccination with recombinant Modified Vaccinia Ankara (MVA) viruses expressing single African horse sickness virus VP2 antigens induced cross-reactive virus neutralising antibodies (VNAb) in horses when administered in combination

机译：用重组改性的痘苗病毒疫苗接种疫苗（MVA）病毒表达单一非洲马疾病病毒VP2抗原诱导在组合施用时诱导马匹的交叉反应性病毒中和抗体（VNAB）

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Vaccine》 |2017年第44期|共6页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 other
中图分类医学免疫学;
关键词
African horse sickness; Vaccinia; MVA; VP2;

机译：非洲马疾病;痘苗;MVA;VP2;

相似文献

外文文献
中文文献
专利

1. Vaccination with recombinant Modified Vaccinia Ankara (MVA) viruses expressing single African horse sickness virus VP2 antigens induced cross-reactive virus neutralising antibodies (VNAb) in horses when administered in combination [J] . Vaccine . 2017,第44期

机译：用重组改性的痘苗病毒疫苗接种疫苗（MVA）病毒表达单一非洲马疾病病毒VP2抗原诱导在组合施用时诱导马匹的交叉反应性病毒中和抗体（VNAB）
2. The immunogenicity of recombinant vaccines based on modified Vaccinia Ankara (MVA) viruses expressing African horse sickness virus VP2 antigens depends on the levels of expressed VP2 protein delivered to the host [J] . Calvo-Pinilla Eva, Gubbins Simon, Mertens Peter, Antiviral Research . 2018,第期

机译：基于修饰的痘苗病毒患者的重组疫苗的免疫原性表达非洲马病病毒VP2抗原的病毒取决于所表达的VP2蛋白递送给宿主的水平
3. Vaccination of horses with a recombinant modified vaccinia Ankara virus (MVA) expressing African horse sickness (AHS) virus major capsid protein VP2 provides complete clinical protection against challenge. [J] . Alberca B., Bachanek-Bankowska K., Cabana M., Vaccine . 2014,第29期

机译：用表达非洲马瘟（AHS）病毒主要衣壳蛋白VP2的重组修饰牛痘安卡拉病毒（MVA）接种马匹，可提供针对挑战的完整临床保护。
4. AFRICAN HORSE SICKNESS VIRUS INDUCES THE INTRINSIC APOPTOSIS PATHWAY IN CULTURED MAMMALIAN CELLS [C] . L. Stassen, H. Huismans, A. N. Hall, Annual Conference of the Microscopy Society of Southern Africa . 2011

机译：非洲马疾病病毒诱导培养的哺乳动物细胞中的内在凋亡途径
5. The immune response in horses to vaccination against equine influenza virus. A comparison of recombinant DNA, inactivated-virus, and modified-live virus vaccines. [D] . Sweat, James Mark. 2001

机译：马对马流感病毒疫苗的免疫反应。重组DNA，灭活病毒和改良活病毒疫苗的比较。
6. The immunogenicity of recombinant vaccines based on modified Vaccinia Ankara (MVA) viruses expressing African horse sickness virus VP2 antigens depends on the levels of expressed VP2 protein delivered to the host [O] . Eva Calvo-Pinilla, Simon Gubbins, Peter Mertens, -1

机译：基于表达非洲马瘟病毒VP2抗原的改良痘苗安卡拉（MVA）病毒的重组疫苗的免疫原性取决于递送至宿主的VP2蛋白表达水平
7. Vaccination of mice with a modified Vaccinia Ankara (MVA) virus expressing the African horse sickness virus (AHSV) capsid protein VP2 induces virus neutralising antibodies that confer protection against AHSV upon passive immunisation [O] . Calvo-Pinilla Eva, de la Poza Francisco, Gubbins Simon, 2014

机译：用表达非洲马瘟病毒（AHSV）衣壳蛋白VP2的改良痘苗安卡拉（MVA）病毒对小鼠进行疫苗接种可诱导病毒中和抗体，从而在被动免疫后赋予针对AHSV的保护

Vaccination with recombinant Modified Vaccinia Ankara (MVA) viruses expressing single African horse sickness virus VP2 antigens induced cross-reactive virus neutralising antibodies (VNAb) in horses when administered in combination

著录项

相似文献

相关主题

期刊订阅